Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C

Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well known. Recently, interferon-induced sarcoidosis has been reported. We report a new case of sarcoidosis during pegylated interferon alfa and ribavirin treatment with an unusual presentation in a woman with...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Lojo, R., Almagro, M., Barja, J. M., Piñeyro, F., Pérez-Varela, L., Del Pozo, J., Yebra-Pimentel, M. T., Fonseca, E.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879954/
https://www.ncbi.nlm.nih.gov/pubmed/20585599
http://dx.doi.org/10.1155/2010/230417
_version_ 1782181974642786304
author Rodríguez-Lojo, R.
Almagro, M.
Barja, J. M.
Piñeyro, F.
Pérez-Varela, L.
Del Pozo, J.
Yebra-Pimentel, M. T.
Fonseca, E.
author_facet Rodríguez-Lojo, R.
Almagro, M.
Barja, J. M.
Piñeyro, F.
Pérez-Varela, L.
Del Pozo, J.
Yebra-Pimentel, M. T.
Fonseca, E.
author_sort Rodríguez-Lojo, R.
collection PubMed
description Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well known. Recently, interferon-induced sarcoidosis has been reported. We report a new case of sarcoidosis during pegylated interferon alfa and ribavirin treatment with an unusual presentation in a woman with previous episodes of erythema nodusum and nodular vasculitis related to HCV.
format Text
id pubmed-2879954
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-28799542010-06-28 Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C Rodríguez-Lojo, R. Almagro, M. Barja, J. M. Piñeyro, F. Pérez-Varela, L. Del Pozo, J. Yebra-Pimentel, M. T. Fonseca, E. Dermatol Res Pract Case Report Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well known. Recently, interferon-induced sarcoidosis has been reported. We report a new case of sarcoidosis during pegylated interferon alfa and ribavirin treatment with an unusual presentation in a woman with previous episodes of erythema nodusum and nodular vasculitis related to HCV. Hindawi Publishing Corporation 2010 2010-04-29 /pmc/articles/PMC2879954/ /pubmed/20585599 http://dx.doi.org/10.1155/2010/230417 Text en Copyright © 2010 R. Rodríguez-Lojo et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Rodríguez-Lojo, R.
Almagro, M.
Barja, J. M.
Piñeyro, F.
Pérez-Varela, L.
Del Pozo, J.
Yebra-Pimentel, M. T.
Fonseca, E.
Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
title Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
title_full Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
title_fullStr Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
title_full_unstemmed Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
title_short Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
title_sort subcutaneous sarcoidosis during pegylated interferon alfa and ribavirin treatment for chronic hepatitis c
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879954/
https://www.ncbi.nlm.nih.gov/pubmed/20585599
http://dx.doi.org/10.1155/2010/230417
work_keys_str_mv AT rodriguezlojor subcutaneoussarcoidosisduringpegylatedinterferonalfaandribavirintreatmentforchronichepatitisc
AT almagrom subcutaneoussarcoidosisduringpegylatedinterferonalfaandribavirintreatmentforchronichepatitisc
AT barjajm subcutaneoussarcoidosisduringpegylatedinterferonalfaandribavirintreatmentforchronichepatitisc
AT pineyrof subcutaneoussarcoidosisduringpegylatedinterferonalfaandribavirintreatmentforchronichepatitisc
AT perezvarelal subcutaneoussarcoidosisduringpegylatedinterferonalfaandribavirintreatmentforchronichepatitisc
AT delpozoj subcutaneoussarcoidosisduringpegylatedinterferonalfaandribavirintreatmentforchronichepatitisc
AT yebrapimentelmt subcutaneoussarcoidosisduringpegylatedinterferonalfaandribavirintreatmentforchronichepatitisc
AT fonsecae subcutaneoussarcoidosisduringpegylatedinterferonalfaandribavirintreatmentforchronichepatitisc

Ejemplares similares